Skip to Main Content

File this under “Nice try, but …

An Ohio congresswoman unsuccessfully attempted to make it possible for the U.S. Department of Health and Human Services to conduct an end run around companies that price drugs —  developed with taxpayer dollars — higher than what is charged in seven other high-income countries.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED